Snowden Capital Advisors LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Snowden Capital Advisors LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$463,734
-11.3%
12,089
+35.9%
0.01%
-12.5%
Q1 2024$523,024
-4.6%
8,898
-2.9%
0.02%
-23.8%
Q4 2023$548,437
+52.6%
9,162
-3.0%
0.02%
+40.0%
Q3 2023$359,478
-34.6%
9,450
+56.6%
0.02%
-25.0%
Q2 2023$549,606
+42.3%
6,033
+3.1%
0.02%
+33.3%
Q1 2023$386,130
+39.6%
5,854
-46.4%
0.02%
-46.4%
Q2 2019$276,56110,9140.03%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders